CKD Corporation
6407・Prime Market・Machinery
Automatic Machinery Division
Large-scale equipment business providing pharmaceutical packaging machines and battery manufacturing systems on a build-to-order basis
| Period | Current | Previous | Change |
|---|---|---|---|
| Revenue (full year, FY2026 ending March 2026) | ¥19,373 million | ¥25,331 million | ↓ |
| Segment profit (full year, FY2026 ending March 2026) | ¥4,879 million | ¥5,489 million | ↓ |
| Revenue YoY change | -23.5% | — | ↓ |
| Segment profit YoY change | -11.1% | — | ↓ |
| Orders received (full year, FY2026 ending March 2026) | ¥19,103 million | — | ↓ |
| Order backlog (fiscal year-end, FY2026 ending March 2026) | ¥16,610 million | — | ↓ |
| Production volume (full year, FY2026 ending March 2026) | ¥19,092 million | — | ↓ |
Business Details
The Automatic Machinery Division manufactures and sells large-scale equipment, primarily Automatic Packaging Systems (Pharmaceuticals, Food, Medical Devices, etc.) and Lithium-ion Battery Manufacturing Systems, on a build-to-order basis. Main customers are pharmaceutical manufacturers (for generic drugs) and automobile manufacturers (for HEV/BEV in-vehicle batteries). The division also offers Packaging Services centered on maintenance and refurbishment of packaging machines, contributing to margin improvement.
Recent Overview
Revenue declined for pharmaceutical packaging machines and battery manufacturing systems, but margins improved due to steady Packaging Services performance
In FY2026 (ending March 2026), the Automatic Machinery Division recorded revenue of ¥19,373 million (down 23.5% year on year) and segment profit of ¥4,879 million (down 11.1% year on year), a significant decline in both revenue and profit. The main causes were a decrease in pharmaceutical packaging machines following the completion of large-scale investment cycles for generic drugs, and a decline in Lithium-ion Battery Manufacturing Systems due to more cautious capital investment by Japanese automobile manufacturers for BEVs. On the other hand, Packaging Services, centered on maintenance and refurbishment of packaging machines, performed steadily, improving margins. Orders received totaled ¥19,103 million (down 13.2% year on year), and the order backlog stood at ¥16,610 million (down 1.5% year on year).
Key Products
Growth Drivers
- Continued margin improvement effect from steady performance of Packaging Services (maintenance and refurbishment)
- Partial recovery in HEV-related in-vehicle battery equipment investment by Japanese automobile manufacturers
- Certain level of capital investment demand in the pharmaceutical market driven by ongoing supply shortages
- Latent demand for Lithium-ion Battery Manufacturing Systems toward a medium- to long-term recovery in the BEV market
- Expansion of environmentally friendly products (eco-scrap technology, biomass plastic packaging machines)
Risks
- Continued sluggish demand for pharmaceutical packaging machines due to the completion of large-scale domestic generic drug investment cycles
- Risk of Japanese automobile manufacturers becoming more cautious about or postponing BEV in-vehicle battery equipment investment
- Risk of fluctuations in revenue recognition timing due to the build-to-order production method (declining trend in order backlog)
- Uncertainty in capital investment demand due to heightened geopolitical risk and policy trends in various countries
- Risk of order fluctuations due to changes in demand outlook for the HEV/BEV market
Last updated: June 25, 2026